Literature DB >> 6380553

The immunocytochemical detection of axillary micrometastases in breast cancer.

C A Wells, A Heryet, J Brochier, K C Gatter, D Y Mason.   

Abstract

The histological detection of tumour metastases in axillary lymph nodes from cases of breast carcinoma is of major prognostic significance, but may be difficult when metastases are of microscopic size. We have therefore investigated whether immunohistological techniques can increase the accuracy of metastasis detection in axillary lymph nodes. Forty-five cases of breast carcinoma were studied, in all of whom the axillary lymph nodes had been reported as free of metastases. Paraffin sections from these cases were stained by immunoenzymatic techniques, using monoclonal antibodies directed against human milk fat globule membrane antigen ("anti-EMA") and against epithelial intermediate filaments ("anti-keratin"). In 4/12 cases of lobular carcinoma and in 3/33 cases of ductal carcinoma, previously unsuspected micrometastases were revealed by immunohistological staining, representing an overall increase in detection rate of 15% (and of 33% for the lobular carcinoma cases). In addition to this group of 45 histologically "negative" biopsies, 12 samples were studied in which only a proportion of the nodes had been reported as containing tumour. In 5 of these cases immunostaining revealed previously undetected metastases. These findings suggest that immunohistological analysis may have a routine role to play in the staging of breast carcinoma. It is noted that the 15% increase in diagnostic accuracy achieved in the present study is comparable to the proportion of breast carcinoma patients in whom disseminated disease develops despite their axillary lymph nodes being reported as tumour-free at the time of surgery.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6380553      PMCID: PMC1976865          DOI: 10.1038/bjc.1984.162

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  12 in total

1.  Pathologic findings from the National Surgical Adjuvant Breast Project (Protocol No. 4). V. Significance of axillary nodal micro- and macrometastases.

Authors:  E R Fisher; A Palekar; H Rockette; C Redmond; B Fisher
Journal:  Cancer       Date:  1978-10       Impact factor: 6.860

2.  Significance of axillary macrometastases and micrometastases in mammary cancer.

Authors:  A G Huvos; R V Hutter; J W Berg
Journal:  Ann Surg       Date:  1971-01       Impact factor: 12.969

3.  Immunocytochemical staining with monoclonal antibodies in cytologically "negative" serous effusions from patients with malignant disease.

Authors:  A K Ghosh; D Y Mason; A I Spriggs
Journal:  J Clin Pathol       Date:  1983-10       Impact factor: 3.411

4.  Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes).

Authors:  J L Cordell; B Falini; W N Erber; A K Ghosh; Z Abdulaziz; S MacDonald; K A Pulford; H Stein; D Y Mason
Journal:  J Histochem Cytochem       Date:  1984-02       Impact factor: 2.479

5.  Use of monoclonal antibodies for the histopathological diagnosis of human malignancy.

Authors:  K C Gatter; Z Abdulaziz; P Beverley; J R Corvalan; C Ford; E B Lane; M Mota; J R Nash; K Pulford; H Stein; J Taylor-Papadimitriou; C Woodhouse; D Y Mason
Journal:  J Clin Pathol       Date:  1982-11       Impact factor: 3.411

Review 6.  Adjuvant chemotherapy of breast cancer.

Authors:  G Bonadonna
Journal:  Br J Hosp Med       Date:  1980-01

7.  Monoclonal antibodies to epithelium-specific components of the human milk fat globule membrane: production and reaction with cells in culture.

Authors:  J Taylor-Papadimitriou; J A Peterson; J Arklie; J Burchell; R L Ceriani; W F Bodmer
Journal:  Int J Cancer       Date:  1981-07-15       Impact factor: 7.396

8.  Axillary micrometastasis and macrometastasis in carcinoma of the breast.

Authors:  F F Attiyeh; M Jensen; A G Huvos; A Fracchia
Journal:  Surg Gynecol Obstet       Date:  1977-06

9.  The use of antisera to epithelial membrane antigen in detecting micrometastases in histological sections.

Authors:  J P Sloane; M G Ormerod; S F Imrie; R C Coombes
Journal:  Br J Cancer       Date:  1980-09       Impact factor: 7.640

10.  The cancer research campaign (King's/Cambridge trial for early breast cancer: clinico-pathological aspects.

Authors:  C W Elston; G A Gresham; G S Rao; T Zebro; J L Haybittle; J Houghton; G Kearney
Journal:  Br J Cancer       Date:  1982-05       Impact factor: 7.640

View more
  22 in total

Review 1.  Axillary staging of breast cancer and the sentinel node.

Authors:  G Cserni
Journal:  J Clin Pathol       Date:  2000-10       Impact factor: 3.411

2.  The Nottingham Prognostic Index in primary breast cancer.

Authors:  M H Galea; R W Blamey; C E Elston; I O Ellis
Journal:  Breast Cancer Res Treat       Date:  1992       Impact factor: 4.872

3.  [Founding a "Lymph Node Metastasis" Study Group at the West German Tumor Center (WTZE)].

Authors:  M Schenck; F vom Dorp; C Boergermann; Y Busch; A Carpinteiro; B Wilker; S Keitsch; K W Schmid; M Groneberg; M Stuschke; H Ruebben; E Gulbins
Journal:  Urologe A       Date:  2007-09       Impact factor: 0.639

4.  Clinical significance of lymph node micrometastasis in ampullary carcinoma.

Authors:  Eiko Sakata; Yoshio Shirai; Naoyuki Yokoyama; Toshifumi Wakai; Jun Sakata; Katsuyoshi Hatakeyama
Journal:  World J Surg       Date:  2006-06       Impact factor: 3.352

5.  Use of immunohistochemical staining panel for characterisation of ovarian neoplasms.

Authors:  P Ashorn; M Helle; H Helin; R Ashorn; K Krohn
Journal:  J Clin Pathol       Date:  1988-01       Impact factor: 3.411

6.  Micrometastatic cancer cells in bone marrow: in vitro detection with anti-cytokeratin and in vivo labeling with anti-17-1A monoclonal antibodies.

Authors:  G Schlimok; I Funke; B Holzmann; G Göttlinger; G Schmidt; H Häuser; S Swierkot; H H Warnecke; B Schneider; H Koprowski; G Riethmüller
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

Review 7.  The role of immunocytochemistry in diagnostic pathology.

Authors:  D Y Mason; K C Gatter
Journal:  J Clin Pathol       Date:  1987-09       Impact factor: 3.411

8.  Human lung tumours may coexpress different classes of intermediate filaments.

Authors:  K C Gatter; M S Dunnill; G N Van Muijen; D Y Mason
Journal:  J Clin Pathol       Date:  1986-09       Impact factor: 3.411

9.  Incidence and impact of documented eradication of breast cancer axillary lymph node metastases before surgery in patients treated with neoadjuvant chemotherapy.

Authors:  H M Kuerer; A A Sahin; K K Hunt; L A Newman; T M Breslin; F C Ames; M I Ross; A U Buzdar; G N Hortobagyi; S E Singletary
Journal:  Ann Surg       Date:  1999-07       Impact factor: 12.969

10.  The value of cytokeratin immunohistochemistry in the evaluation of axillary sentinel lymph nodes in patients with lobular breast carcinoma.

Authors:  G Cserni; S Bianchi; V Vezzosi; H Peterse; A Sapino; R Arisio; A Reiner-Concin; P Regitnig; J-P Bellocq; C Marin; R Bori; J M Penuela; A Córdoba Iturriagagoitia
Journal:  J Clin Pathol       Date:  2006-02-23       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.